Ironwood Pharmaceuticals Stock Investor Sentiment
| IRWD Stock | USD 1.50 0.01 0.67% |
About 57% of Ironwood Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Ironwood Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Ironwood Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Ironwood Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Comfort Level 43
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ironwood Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ironwood Pharmaceuticals.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Ironwood Historical Sentiment
Although Ironwood Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Ironwood, such as negative comments on social media and news outlets, may cause fear in the market and push Ironwood Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Ironwood.
Ironwood |
Ironwood Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Ironwood Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ironwood Pharmaceuticals Historical Investor Sentiment
Investor biases related to Ironwood Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ironwood. The trend in average sentiment can be used to explain how an investor holding Ironwood can time the market purely based on public headlines and social activities around Ironwood Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ironwood Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ironwood Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ironwood Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Ironwood Pharmaceuticals.
Far too much social signal, news, headlines, and media speculation about Ironwood Pharmaceuticals that are available to investors today. That information is available publicly through Ironwood media outlets and privately through word of mouth or via Ironwood internal channels. However, regardless of the origin, that massive amount of Ironwood data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ironwood Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ironwood Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ironwood Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ironwood Pharmaceuticals alpha.
Ironwood Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Moukheibir Catherine of 22350 shares of Ironwood Pharmaceuticals subject to Rule 16b-3 | 01/15/2025 |
2 | Acquisition by Currie Mark G of 24311 shares of Ironwood Pharmaceuticals subject to Rule 16b-3 | 01/17/2025 |
3 | Insider Trading | 01/27/2025 |
4 | Ironwood Pharmaceuticals announces workforce reduction - Investing.com | 01/29/2025 |
5 | Disposition of 12052 shares by Greg Martini of Ironwood Pharmaceuticals at 1.76 subject to Rule 16b-3 | 02/10/2025 |
6 | What is Zacks Researchs Forecast for IRWD Q1 Earnings | 02/14/2025 |
7 | Ironwood Pharmaceuticals, Inc. Sees Significant Increase in Short Interest | 02/18/2025 |
8 | Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call | 02/20/2025 |
9 | Brokerages Set Ironwood Pharmaceuticals, Inc. Target Price at 8.60 | 02/27/2025 |
10 | Ironwood Pharmaceuticals, Inc. Q4 2024 Earnings Call Transcript | 02/28/2025 |
11 | Acquisition by Shetzline Michael of 34936 shares of Ironwood Pharmaceuticals subject to Rule 16b-3 | 03/05/2025 |
12 | Acquisition by Denner Alexander J of 2572 shares of Ironwood Pharmaceuticals subject to Rule 16b-3 | 03/18/2025 |
13 | Sarissa Capital Management LP Reduces Stake in Innoviva Inc. | 03/21/2025 |
Complementary Tools for Ironwood Stock analysis
When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |